nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RARA—myometrium—ovarian cancer	0.00779	0.0561	CbGeAlD
Isotretinoin—RXRB—decidua—ovarian cancer	0.00692	0.0498	CbGeAlD
Isotretinoin—RXRA—female reproductive system—ovarian cancer	0.00659	0.0475	CbGeAlD
Isotretinoin—RARG—decidua—ovarian cancer	0.00614	0.0442	CbGeAlD
Isotretinoin—RXRA—female gonad—ovarian cancer	0.006	0.0432	CbGeAlD
Isotretinoin—RARB—female reproductive system—ovarian cancer	0.00592	0.0426	CbGeAlD
Isotretinoin—RARA—decidua—ovarian cancer	0.00578	0.0416	CbGeAlD
Isotretinoin—RARA—endometrium—ovarian cancer	0.00548	0.0395	CbGeAlD
Isotretinoin—RARB—female gonad—ovarian cancer	0.00539	0.0388	CbGeAlD
Isotretinoin—RARG—uterus—ovarian cancer	0.00537	0.0387	CbGeAlD
Isotretinoin—RARB—vagina—ovarian cancer	0.00536	0.0386	CbGeAlD
Isotretinoin—RARA—gonad—ovarian cancer	0.00509	0.0366	CbGeAlD
Isotretinoin—RARA—uterus—ovarian cancer	0.00505	0.0364	CbGeAlD
Isotretinoin—RXRB—female gonad—ovarian cancer	0.00495	0.0357	CbGeAlD
Isotretinoin—RXRB—vagina—ovarian cancer	0.00492	0.0354	CbGeAlD
Isotretinoin—RARG—female reproductive system—ovarian cancer	0.00483	0.0348	CbGeAlD
Isotretinoin—RXRG—testis—ovarian cancer	0.00467	0.0336	CbGeAlD
Isotretinoin—RARA—female reproductive system—ovarian cancer	0.00454	0.0327	CbGeAlD
Isotretinoin—RARG—female gonad—ovarian cancer	0.0044	0.0316	CbGeAlD
Isotretinoin—RXRB—testis—ovarian cancer	0.00439	0.0316	CbGeAlD
Isotretinoin—RARG—vagina—ovarian cancer	0.00437	0.0315	CbGeAlD
Isotretinoin—RARA—bone marrow—ovarian cancer	0.00429	0.0309	CbGeAlD
Isotretinoin—RARA—female gonad—ovarian cancer	0.00413	0.0298	CbGeAlD
Isotretinoin—RARG—testis—ovarian cancer	0.0039	0.0281	CbGeAlD
Isotretinoin—RARA—testis—ovarian cancer	0.00367	0.0264	CbGeAlD
Isotretinoin—RARB—lymph node—ovarian cancer	0.00346	0.0249	CbGeAlD
Isotretinoin—RARG—lymph node—ovarian cancer	0.00283	0.0203	CbGeAlD
Isotretinoin—RARA—lymph node—ovarian cancer	0.00266	0.0191	CbGeAlD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—CDH1—ovarian cancer	0.000674	0.00228	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IL6ST—ovarian cancer	0.000666	0.00226	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.00066	0.00224	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—ovarian cancer	0.000656	0.00222	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—ovarian cancer	0.000646	0.00219	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.00064	0.00217	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.00064	0.00217	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000633	0.00215	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000628	0.00213	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—WDR77—ovarian cancer	0.000628	0.00213	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IL6ST—ovarian cancer	0.000626	0.00212	CbGpPWpGaD
Isotretinoin—RXRA—PPAR Alpha Pathway—MYC—ovarian cancer	0.000625	0.00212	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—WDR77—ovarian cancer	0.000616	0.00209	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000613	0.00208	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000613	0.00208	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—ovarian cancer	0.000607	0.00206	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000602	0.00204	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—WDR77—ovarian cancer	0.00059	0.002	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—WDR77—ovarian cancer	0.00059	0.002	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—GADD45A—ovarian cancer	0.00058	0.00196	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—YAP1—ovarian cancer	0.000579	0.00196	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—MAPK3—ovarian cancer	0.000573	0.00194	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—ovarian cancer	0.00057	0.00193	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—ovarian cancer	0.000569	0.00193	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—ovarian cancer	0.000548	0.00186	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—MAPK1—ovarian cancer	0.000545	0.00185	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—TTF1—ovarian cancer	0.000539	0.00183	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—ovarian cancer	0.000537	0.00182	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—ovarian cancer	0.000536	0.00182	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—YAP1—ovarian cancer	0.00053	0.0018	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—YAP1—ovarian cancer	0.00052	0.00176	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SLC5A5—ovarian cancer	0.00052	0.00176	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—PGR—ovarian cancer	0.000506	0.00171	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SLC2A1—ovarian cancer	0.000502	0.0017	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—YAP1—ovarian cancer	0.000498	0.00169	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—YAP1—ovarian cancer	0.000498	0.00169	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—TTF1—ovarian cancer	0.000493	0.00167	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NR5A1—ovarian cancer	0.000489	0.00166	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000488	0.00165	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—TTF1—ovarian cancer	0.000483	0.00164	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—PARP1—ovarian cancer	0.00047	0.00159	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000468	0.00158	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—TTF1—ovarian cancer	0.000463	0.00157	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—TTF1—ovarian cancer	0.000463	0.00157	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—PGR—ovarian cancer	0.000463	0.00157	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000461	0.00156	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NR5A1—ovarian cancer	0.000455	0.00154	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—PGR—ovarian cancer	0.000454	0.00154	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NR5A1—ovarian cancer	0.000447	0.00152	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—ovarian cancer	0.000447	0.00151	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000442	0.0015	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NR5A1—ovarian cancer	0.000439	0.00149	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—PGR—ovarian cancer	0.000435	0.00147	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—PGR—ovarian cancer	0.000435	0.00147	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—CTNNB1—ovarian cancer	0.000435	0.00147	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—PARP1—ovarian cancer	0.00043	0.00146	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NR5A1—ovarian cancer	0.000429	0.00145	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000426	0.00144	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP1B1—ovarian cancer	0.000422	0.00143	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—PARP1—ovarian cancer	0.000422	0.00143	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NR5A1—ovarian cancer	0.000421	0.00143	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NR5A1—ovarian cancer	0.000421	0.00143	CbGpPWpGaD
Isotretinoin—RXRA—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	0.000409	0.00139	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—CTNNB1—ovarian cancer	0.000409	0.00138	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—PARP1—ovarian cancer	0.000404	0.00137	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—PARP1—ovarian cancer	0.000404	0.00137	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—ovarian cancer	0.000394	0.00134	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000389	0.00132	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—ovarian cancer	0.000387	0.00131	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—STAT3—ovarian cancer	0.000379	0.00128	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000365	0.00124	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000358	0.00121	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—STAT3—ovarian cancer	0.000356	0.00121	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000343	0.00116	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—ovarian cancer	0.000342	0.00116	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000332	0.00112	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.00033	0.00112	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000329	0.00112	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IL6ST—ovarian cancer	0.000326	0.00111	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000325	0.0011	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000325	0.0011	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.00032	0.00108	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.00032	0.00108	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000318	0.00108	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—ovarian cancer	0.000316	0.00107	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000316	0.00107	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HNF1B—ovarian cancer	0.000316	0.00107	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000316	0.00107	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000314	0.00106	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000313	0.00106	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000312	0.00106	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—WDR77—ovarian cancer	0.000308	0.00104	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000305	0.00103	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000303	0.00103	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.0003	0.00102	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000293	0.000992	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—ovarian cancer	0.000279	0.000947	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—YAP1—ovarian cancer	0.000279	0.000945	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000276	0.000935	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—ESR1—ovarian cancer	0.00027	0.000916	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IL6—ovarian cancer	0.000265	0.000897	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000264	0.000896	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000261	0.000884	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—YAP1—ovarian cancer	0.00026	0.00088	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NME2—ovarian cancer	0.000257	0.000872	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—YAP1—ovarian cancer	0.000255	0.000865	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000254	0.00086	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—YAP1—ovarian cancer	0.00025	0.000848	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.00025	0.000848	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000249	0.000845	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IL6—ovarian cancer	0.000249	0.000843	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000248	0.000841	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000248	0.000841	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—ESR1—ovarian cancer	0.000247	0.000837	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000244	0.000826	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—PGR—ovarian cancer	0.000244	0.000826	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000243	0.000824	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—ESR1—ovarian cancer	0.000242	0.000821	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—TTF1—ovarian cancer	0.000241	0.000818	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—YAP1—ovarian cancer	0.00024	0.000813	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—YAP1—ovarian cancer	0.00024	0.000813	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000238	0.000807	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000238	0.000806	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000234	0.000795	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ESR1—ovarian cancer	0.000232	0.000787	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—ESR1—ovarian cancer	0.000232	0.000787	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.00023	0.000781	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—PGR—ovarian cancer	0.000227	0.000768	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—PARP1—ovarian cancer	0.000226	0.000768	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000225	0.000762	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PGR—ovarian cancer	0.000223	0.000755	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NR5A1—ovarian cancer	0.000219	0.000743	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PGR—ovarian cancer	0.000218	0.00074	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000218	0.00074	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000215	0.00073	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—CTNNB1—ovarian cancer	0.000213	0.000722	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—PARP1—ovarian cancer	0.000211	0.000714	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PGR—ovarian cancer	0.000209	0.00071	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PGR—ovarian cancer	0.000209	0.00071	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000208	0.000706	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PARP1—ovarian cancer	0.000207	0.000702	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000206	0.0007	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PARP1—ovarian cancer	0.000203	0.000688	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.0002	0.000677	CbGpPWpGaD
Isotretinoin—Dyspepsia—Paclitaxel—ovarian cancer	0.000197	0.000349	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000197	0.000348	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000197	0.000348	CcSEcCtD
Isotretinoin—Stomatitis—Epirubicin—ovarian cancer	0.000196	0.000346	CcSEcCtD
Isotretinoin—Urinary tract infection—Epirubicin—ovarian cancer	0.000195	0.000345	CcSEcCtD
Isotretinoin—Conjunctivitis—Epirubicin—ovarian cancer	0.000195	0.000345	CcSEcCtD
Isotretinoin—Neutropenia—Doxorubicin—ovarian cancer	0.000195	0.000345	CcSEcCtD
Isotretinoin—Dysuria—Doxorubicin—ovarian cancer	0.000195	0.000345	CcSEcCtD
Isotretinoin—Decreased appetite—Paclitaxel—ovarian cancer	0.000195	0.000344	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—PARP1—ovarian cancer	0.000195	0.00066	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PARP1—ovarian cancer	0.000195	0.00066	CbGpPWpGaD
Isotretinoin—Dry mouth—Docetaxel—ovarian cancer	0.000194	0.000342	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000194	0.000342	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000194	0.000342	CcSEcCtD
Isotretinoin—Fatigue—Paclitaxel—ovarian cancer	0.000193	0.000341	CcSEcCtD
Isotretinoin—Sweating—Epirubicin—ovarian cancer	0.000193	0.00034	CcSEcCtD
Isotretinoin—Pollakiuria—Doxorubicin—ovarian cancer	0.000193	0.00034	CcSEcCtD
Isotretinoin—Constipation—Paclitaxel—ovarian cancer	0.000192	0.000339	CcSEcCtD
Isotretinoin—Pain—Paclitaxel—ovarian cancer	0.000192	0.000339	CcSEcCtD
Isotretinoin—Haematuria—Epirubicin—ovarian cancer	0.000192	0.000339	CcSEcCtD
Isotretinoin—Confusional state—Docetaxel—ovarian cancer	0.000192	0.000338	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00019	0.000336	CcSEcCtD
Isotretinoin—Oedema—Docetaxel—ovarian cancer	0.00019	0.000336	CcSEcCtD
Isotretinoin—Anaphylactic shock—Docetaxel—ovarian cancer	0.00019	0.000336	CcSEcCtD
Isotretinoin—Weight increased—Doxorubicin—ovarian cancer	0.00019	0.000335	CcSEcCtD
Isotretinoin—Epistaxis—Epirubicin—ovarian cancer	0.00019	0.000335	CcSEcCtD
Isotretinoin—Infection—Docetaxel—ovarian cancer	0.000189	0.000334	CcSEcCtD
Isotretinoin—Weight decreased—Doxorubicin—ovarian cancer	0.000189	0.000333	CcSEcCtD
Isotretinoin—Sinusitis—Epirubicin—ovarian cancer	0.000189	0.000333	CcSEcCtD
Isotretinoin—Agranulocytosis—Epirubicin—ovarian cancer	0.000188	0.000331	CcSEcCtD
Isotretinoin—Pneumonia—Doxorubicin—ovarian cancer	0.000187	0.00033	CcSEcCtD
Isotretinoin—Shock—Docetaxel—ovarian cancer	0.000187	0.00033	CcSEcCtD
Isotretinoin—Nervous system disorder—Docetaxel—ovarian cancer	0.000186	0.000329	CcSEcCtD
Isotretinoin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000186	0.000329	CcSEcCtD
Isotretinoin—Infestation—Doxorubicin—ovarian cancer	0.000186	0.000328	CcSEcCtD
Isotretinoin—Drowsiness—Doxorubicin—ovarian cancer	0.000186	0.000328	CcSEcCtD
Isotretinoin—Infestation NOS—Doxorubicin—ovarian cancer	0.000186	0.000328	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—STAT3—ovarian cancer	0.000186	0.000629	CbGpPWpGaD
Isotretinoin—Tachycardia—Docetaxel—ovarian cancer	0.000185	0.000328	CcSEcCtD
Isotretinoin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000185	0.000326	CcSEcCtD
Isotretinoin—Skin disorder—Docetaxel—ovarian cancer	0.000185	0.000326	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000184	0.000326	CcSEcCtD
Isotretinoin—RARG—Gene Expression—PPP2R1A—ovarian cancer	0.000184	0.000623	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000183	0.000324	CcSEcCtD
Isotretinoin—Renal failure—Doxorubicin—ovarian cancer	0.000183	0.000323	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000182	0.000322	CcSEcCtD
Isotretinoin—Haemoglobin—Epirubicin—ovarian cancer	0.000181	0.00032	CcSEcCtD
Isotretinoin—Stomatitis—Doxorubicin—ovarian cancer	0.000181	0.00032	CcSEcCtD
Isotretinoin—Anorexia—Docetaxel—ovarian cancer	0.000181	0.00032	CcSEcCtD
Isotretinoin—Conjunctivitis—Doxorubicin—ovarian cancer	0.000181	0.000319	CcSEcCtD
Isotretinoin—Urinary tract infection—Doxorubicin—ovarian cancer	0.000181	0.000319	CcSEcCtD
Isotretinoin—Haemorrhage—Epirubicin—ovarian cancer	0.00018	0.000319	CcSEcCtD
Isotretinoin—Hepatitis—Epirubicin—ovarian cancer	0.00018	0.000319	CcSEcCtD
Isotretinoin—Hypoaesthesia—Epirubicin—ovarian cancer	0.00018	0.000317	CcSEcCtD
Isotretinoin—Pharyngitis—Epirubicin—ovarian cancer	0.000179	0.000316	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000179	0.000606	CbGpPWpGaD
Isotretinoin—Sweating—Doxorubicin—ovarian cancer	0.000178	0.000315	CcSEcCtD
Isotretinoin—Urinary tract disorder—Epirubicin—ovarian cancer	0.000178	0.000315	CcSEcCtD
Isotretinoin—Urticaria—Paclitaxel—ovarian cancer	0.000178	0.000315	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000178	0.000603	CbGpPWpGaD
Isotretinoin—Oedema peripheral—Epirubicin—ovarian cancer	0.000178	0.000314	CcSEcCtD
Isotretinoin—Hypotension—Docetaxel—ovarian cancer	0.000178	0.000314	CcSEcCtD
Isotretinoin—Haematuria—Doxorubicin—ovarian cancer	0.000177	0.000313	CcSEcCtD
Isotretinoin—Body temperature increased—Paclitaxel—ovarian cancer	0.000177	0.000313	CcSEcCtD
Isotretinoin—Abdominal pain—Paclitaxel—ovarian cancer	0.000177	0.000313	CcSEcCtD
Isotretinoin—Urethral disorder—Epirubicin—ovarian cancer	0.000177	0.000312	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000176	0.000596	CbGpPWpGaD
Isotretinoin—Epistaxis—Doxorubicin—ovarian cancer	0.000175	0.00031	CcSEcCtD
Isotretinoin—Sinusitis—Doxorubicin—ovarian cancer	0.000174	0.000308	CcSEcCtD
Isotretinoin—Visual impairment—Epirubicin—ovarian cancer	0.000174	0.000307	CcSEcCtD
Isotretinoin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000174	0.000307	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000173	0.000306	CcSEcCtD
Isotretinoin—Insomnia—Docetaxel—ovarian cancer	0.000172	0.000304	CcSEcCtD
Isotretinoin—Paraesthesia—Docetaxel—ovarian cancer	0.000171	0.000301	CcSEcCtD
Isotretinoin—Erythema multiforme—Epirubicin—ovarian cancer	0.000171	0.000301	CcSEcCtD
Isotretinoin—Dyspnoea—Docetaxel—ovarian cancer	0.000169	0.000299	CcSEcCtD
Isotretinoin—Somnolence—Docetaxel—ovarian cancer	0.000169	0.000298	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000169	0.000572	CbGpPWpGaD
Isotretinoin—Eye disorder—Epirubicin—ovarian cancer	0.000169	0.000298	CcSEcCtD
Isotretinoin—Tinnitus—Epirubicin—ovarian cancer	0.000168	0.000297	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—PPP2R1A—ovarian cancer	0.000168	0.000569	CbGpPWpGaD
Isotretinoin—Haemoglobin—Doxorubicin—ovarian cancer	0.000168	0.000296	CcSEcCtD
Isotretinoin—Flushing—Epirubicin—ovarian cancer	0.000167	0.000296	CcSEcCtD
Isotretinoin—Dyspepsia—Docetaxel—ovarian cancer	0.000167	0.000296	CcSEcCtD
Isotretinoin—Hepatitis—Doxorubicin—ovarian cancer	0.000167	0.000295	CcSEcCtD
Isotretinoin—Haemorrhage—Doxorubicin—ovarian cancer	0.000167	0.000295	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000166	0.000564	CbGpPWpGaD
Isotretinoin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000166	0.000293	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CYTB—ovarian cancer	0.000166	0.000562	CbGpPWpGaD
Isotretinoin—Pharyngitis—Doxorubicin—ovarian cancer	0.000166	0.000293	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000166	0.000561	CbGpPWpGaD
Isotretinoin—Decreased appetite—Docetaxel—ovarian cancer	0.000165	0.000292	CcSEcCtD
Isotretinoin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000165	0.000292	CcSEcCtD
Isotretinoin—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000165	0.000291	CcSEcCtD
Isotretinoin—RARB—Gene Expression—PPP2R1A—ovarian cancer	0.000165	0.000558	CbGpPWpGaD
Isotretinoin—Oedema peripheral—Doxorubicin—ovarian cancer	0.000164	0.000291	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000164	0.00029	CcSEcCtD
Isotretinoin—Fatigue—Docetaxel—ovarian cancer	0.000164	0.000289	CcSEcCtD
Isotretinoin—Angiopathy—Epirubicin—ovarian cancer	0.000164	0.000289	CcSEcCtD
Isotretinoin—Urethral disorder—Doxorubicin—ovarian cancer	0.000164	0.000289	CcSEcCtD
Isotretinoin—Pain—Docetaxel—ovarian cancer	0.000163	0.000287	CcSEcCtD
Isotretinoin—Constipation—Docetaxel—ovarian cancer	0.000163	0.000287	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000162	0.00055	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000162	0.000549	CbGpPWpGaD
Isotretinoin—Chills—Epirubicin—ovarian cancer	0.000162	0.000286	CcSEcCtD
Isotretinoin—Arrhythmia—Epirubicin—ovarian cancer	0.000161	0.000285	CcSEcCtD
Isotretinoin—Visual impairment—Doxorubicin—ovarian cancer	0.000161	0.000284	CcSEcCtD
Isotretinoin—Asthenia—Paclitaxel—ovarian cancer	0.000161	0.000284	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000161	0.000545	CbGpPWpGaD
Isotretinoin—Alopecia—Epirubicin—ovarian cancer	0.000159	0.000282	CcSEcCtD
Isotretinoin—Pruritus—Paclitaxel—ovarian cancer	0.000159	0.00028	CcSEcCtD
Isotretinoin—Mental disorder—Epirubicin—ovarian cancer	0.000158	0.000279	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000158	0.000536	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PPP2R1A—ovarian cancer	0.000158	0.000535	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PPP2R1A—ovarian cancer	0.000158	0.000535	CbGpPWpGaD
Isotretinoin—Erythema multiforme—Doxorubicin—ovarian cancer	0.000158	0.000279	CcSEcCtD
Isotretinoin—Malnutrition—Epirubicin—ovarian cancer	0.000157	0.000277	CcSEcCtD
Isotretinoin—Erythema—Epirubicin—ovarian cancer	0.000157	0.000277	CcSEcCtD
Isotretinoin—Feeling abnormal—Docetaxel—ovarian cancer	0.000157	0.000277	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000157	0.00053	CbGpPWpGaD
Isotretinoin—Eye disorder—Doxorubicin—ovarian cancer	0.000156	0.000276	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—ovarian cancer	0.000156	0.000275	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000155	0.000275	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—ovarian cancer	0.000155	0.000274	CcSEcCtD
Isotretinoin—Flatulence—Epirubicin—ovarian cancer	0.000155	0.000273	CcSEcCtD
Isotretinoin—Tension—Epirubicin—ovarian cancer	0.000154	0.000272	CcSEcCtD
Isotretinoin—Diarrhoea—Paclitaxel—ovarian cancer	0.000153	0.000271	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000153	0.000517	CbGpPWpGaD
Isotretinoin—Nervousness—Epirubicin—ovarian cancer	0.000153	0.000269	CcSEcCtD
Isotretinoin—Back pain—Epirubicin—ovarian cancer	0.000152	0.000268	CcSEcCtD
Isotretinoin—Angiopathy—Doxorubicin—ovarian cancer	0.000151	0.000268	CcSEcCtD
Isotretinoin—Abdominal pain—Docetaxel—ovarian cancer	0.00015	0.000265	CcSEcCtD
Isotretinoin—Body temperature increased—Docetaxel—ovarian cancer	0.00015	0.000265	CcSEcCtD
Isotretinoin—Chills—Doxorubicin—ovarian cancer	0.00015	0.000265	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—ovarian cancer	0.000149	0.000263	CcSEcCtD
Isotretinoin—Dizziness—Paclitaxel—ovarian cancer	0.000148	0.000262	CcSEcCtD
Isotretinoin—Vision blurred—Epirubicin—ovarian cancer	0.000148	0.000261	CcSEcCtD
Isotretinoin—Alopecia—Doxorubicin—ovarian cancer	0.000148	0.000261	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—ovarian cancer	0.000146	0.000258	CcSEcCtD
Isotretinoin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000146	0.000257	CcSEcCtD
Isotretinoin—Malnutrition—Doxorubicin—ovarian cancer	0.000145	0.000257	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—ovarian cancer	0.000145	0.000257	CcSEcCtD
Isotretinoin—Anaemia—Epirubicin—ovarian cancer	0.000145	0.000256	CcSEcCtD
Isotretinoin—RXRA—Metabolism—BRIP1—ovarian cancer	0.000145	0.000491	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PPP1CC—ovarian cancer	0.000145	0.000491	CbGpPWpGaD
Isotretinoin—Agitation—Epirubicin—ovarian cancer	0.000144	0.000255	CcSEcCtD
Isotretinoin—Flatulence—Doxorubicin—ovarian cancer	0.000143	0.000253	CcSEcCtD
Isotretinoin—Tension—Doxorubicin—ovarian cancer	0.000143	0.000252	CcSEcCtD
Isotretinoin—Vomiting—Paclitaxel—ovarian cancer	0.000143	0.000252	CcSEcCtD
Isotretinoin—Malaise—Epirubicin—ovarian cancer	0.000142	0.00025	CcSEcCtD
Isotretinoin—Rash—Paclitaxel—ovarian cancer	0.000141	0.00025	CcSEcCtD
Isotretinoin—Dermatitis—Paclitaxel—ovarian cancer	0.000141	0.000249	CcSEcCtD
Isotretinoin—Nervousness—Doxorubicin—ovarian cancer	0.000141	0.000249	CcSEcCtD
Isotretinoin—Syncope—Epirubicin—ovarian cancer	0.000141	0.000249	CcSEcCtD
Isotretinoin—Back pain—Doxorubicin—ovarian cancer	0.000141	0.000248	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—ovarian cancer	0.000141	0.000476	CbGpPWpGaD
Isotretinoin—Headache—Paclitaxel—ovarian cancer	0.00014	0.000248	CcSEcCtD
Isotretinoin—Hypersensitivity—Docetaxel—ovarian cancer	0.00014	0.000247	CcSEcCtD
Isotretinoin—Palpitations—Epirubicin—ovarian cancer	0.000139	0.000245	CcSEcCtD
Isotretinoin—Loss of consciousness—Epirubicin—ovarian cancer	0.000138	0.000244	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000138	0.000467	CbGpPWpGaD
Isotretinoin—Cough—Epirubicin—ovarian cancer	0.000137	0.000242	CcSEcCtD
Isotretinoin—Vision blurred—Doxorubicin—ovarian cancer	0.000137	0.000242	CcSEcCtD
Isotretinoin—Asthenia—Docetaxel—ovarian cancer	0.000136	0.000241	CcSEcCtD
Isotretinoin—Convulsion—Epirubicin—ovarian cancer	0.000136	0.00024	CcSEcCtD
Isotretinoin—Hypertension—Epirubicin—ovarian cancer	0.000136	0.00024	CcSEcCtD
Isotretinoin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000135	0.000238	CcSEcCtD
Isotretinoin—Pruritus—Docetaxel—ovarian cancer	0.000134	0.000238	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—ovarian cancer	0.000134	0.000237	CcSEcCtD
Isotretinoin—Chest pain—Epirubicin—ovarian cancer	0.000134	0.000236	CcSEcCtD
Isotretinoin—Myalgia—Epirubicin—ovarian cancer	0.000134	0.000236	CcSEcCtD
Isotretinoin—Arthralgia—Epirubicin—ovarian cancer	0.000134	0.000236	CcSEcCtD
Isotretinoin—Agitation—Doxorubicin—ovarian cancer	0.000134	0.000236	CcSEcCtD
Isotretinoin—Anxiety—Epirubicin—ovarian cancer	0.000133	0.000235	CcSEcCtD
Isotretinoin—Nausea—Paclitaxel—ovarian cancer	0.000133	0.000235	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000133	0.000235	CcSEcCtD
Isotretinoin—Discomfort—Epirubicin—ovarian cancer	0.000132	0.000233	CcSEcCtD
Isotretinoin—Malaise—Doxorubicin—ovarian cancer	0.000131	0.000231	CcSEcCtD
Isotretinoin—Dry mouth—Epirubicin—ovarian cancer	0.000131	0.000231	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.00013	0.000442	CbGpPWpGaD
Isotretinoin—Syncope—Doxorubicin—ovarian cancer	0.00013	0.00023	CcSEcCtD
Isotretinoin—RARG—Gene Expression—ESR1—ovarian cancer	0.00013	0.000441	CbGpPWpGaD
Isotretinoin—Diarrhoea—Docetaxel—ovarian cancer	0.00013	0.00023	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—IL6—ovarian cancer	0.00013	0.000439	CbGpPWpGaD
Isotretinoin—Confusional state—Epirubicin—ovarian cancer	0.000129	0.000228	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—ovarian cancer	0.000129	0.000436	CbGpPWpGaD
Isotretinoin—Palpitations—Doxorubicin—ovarian cancer	0.000128	0.000227	CcSEcCtD
Isotretinoin—Oedema—Epirubicin—ovarian cancer	0.000128	0.000226	CcSEcCtD
Isotretinoin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000128	0.000226	CcSEcCtD
Isotretinoin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000128	0.000226	CcSEcCtD
Isotretinoin—Infection—Epirubicin—ovarian cancer	0.000127	0.000225	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000127	0.00043	CbGpPWpGaD
Isotretinoin—Cough—Doxorubicin—ovarian cancer	0.000127	0.000224	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000127	0.00043	CbGpPWpGaD
Isotretinoin—Shock—Epirubicin—ovarian cancer	0.000126	0.000223	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—ovarian cancer	0.000126	0.000427	CbGpPWpGaD
Isotretinoin—Convulsion—Doxorubicin—ovarian cancer	0.000126	0.000222	CcSEcCtD
Isotretinoin—Nervous system disorder—Epirubicin—ovarian cancer	0.000126	0.000222	CcSEcCtD
Isotretinoin—Dizziness—Docetaxel—ovarian cancer	0.000126	0.000222	CcSEcCtD
Isotretinoin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000125	0.000222	CcSEcCtD
Isotretinoin—Hypertension—Doxorubicin—ovarian cancer	0.000125	0.000222	CcSEcCtD
Isotretinoin—Tachycardia—Epirubicin—ovarian cancer	0.000125	0.000221	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—YAP1—ovarian cancer	0.000125	0.000424	CbGpPWpGaD
Isotretinoin—Skin disorder—Epirubicin—ovarian cancer	0.000124	0.00022	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000124	0.00042	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000124	0.00042	CbGpPWpGaD
Isotretinoin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000124	0.000219	CcSEcCtD
Isotretinoin—Myalgia—Doxorubicin—ovarian cancer	0.000124	0.000219	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—ovarian cancer	0.000124	0.000219	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—ovarian cancer	0.000124	0.000219	CcSEcCtD
Isotretinoin—Anxiety—Doxorubicin—ovarian cancer	0.000123	0.000218	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000123	0.000217	CcSEcCtD
Isotretinoin—Discomfort—Doxorubicin—ovarian cancer	0.000122	0.000216	CcSEcCtD
Isotretinoin—Anorexia—Epirubicin—ovarian cancer	0.000122	0.000216	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—ESR1—ovarian cancer	0.000121	0.00041	CbGpPWpGaD
Isotretinoin—Dry mouth—Doxorubicin—ovarian cancer	0.000121	0.000214	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—ovarian cancer	0.000121	0.00041	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—ovarian cancer	0.000121	0.00041	CbGpPWpGaD
Isotretinoin—Vomiting—Docetaxel—ovarian cancer	0.000121	0.000213	CcSEcCtD
Isotretinoin—Rash—Docetaxel—ovarian cancer	0.00012	0.000212	CcSEcCtD
Isotretinoin—Hypotension—Epirubicin—ovarian cancer	0.00012	0.000212	CcSEcCtD
Isotretinoin—Dermatitis—Docetaxel—ovarian cancer	0.00012	0.000211	CcSEcCtD
Isotretinoin—Confusional state—Doxorubicin—ovarian cancer	0.00012	0.000211	CcSEcCtD
Isotretinoin—Headache—Docetaxel—ovarian cancer	0.000119	0.00021	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—ESR1—ovarian cancer	0.000119	0.000403	CbGpPWpGaD
Isotretinoin—Oedema—Doxorubicin—ovarian cancer	0.000119	0.00021	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000119	0.00021	CcSEcCtD
Isotretinoin—Infection—Doxorubicin—ovarian cancer	0.000118	0.000208	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000117	0.000397	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000117	0.000206	CcSEcCtD
Isotretinoin—Shock—Doxorubicin—ovarian cancer	0.000117	0.000206	CcSEcCtD
Isotretinoin—RARB—Gene Expression—ESR1—ovarian cancer	0.000117	0.000395	CbGpPWpGaD
Isotretinoin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000116	0.000205	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000116	0.000205	CcSEcCtD
Isotretinoin—Insomnia—Epirubicin—ovarian cancer	0.000116	0.000205	CcSEcCtD
Isotretinoin—Tachycardia—Doxorubicin—ovarian cancer	0.000116	0.000204	CcSEcCtD
Isotretinoin—Skin disorder—Doxorubicin—ovarian cancer	0.000115	0.000204	CcSEcCtD
Isotretinoin—Paraesthesia—Epirubicin—ovarian cancer	0.000115	0.000203	CcSEcCtD
Isotretinoin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000115	0.000203	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—MET—ovarian cancer	0.000114	0.000388	CbGpPWpGaD
Isotretinoin—Dyspnoea—Epirubicin—ovarian cancer	0.000114	0.000202	CcSEcCtD
Isotretinoin—Somnolence—Epirubicin—ovarian cancer	0.000114	0.000201	CcSEcCtD
Isotretinoin—Anorexia—Doxorubicin—ovarian cancer	0.000113	0.0002	CcSEcCtD
Isotretinoin—Nausea—Docetaxel—ovarian cancer	0.000113	0.000199	CcSEcCtD
Isotretinoin—Dyspepsia—Epirubicin—ovarian cancer	0.000113	0.000199	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—IL6ST—ovarian cancer	0.000112	0.00038	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ESR1—ovarian cancer	0.000112	0.000379	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ESR1—ovarian cancer	0.000112	0.000379	CbGpPWpGaD
Isotretinoin—Decreased appetite—Epirubicin—ovarian cancer	0.000111	0.000197	CcSEcCtD
Isotretinoin—Hypotension—Doxorubicin—ovarian cancer	0.000111	0.000196	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000111	0.000195	CcSEcCtD
Isotretinoin—Fatigue—Epirubicin—ovarian cancer	0.000111	0.000195	CcSEcCtD
Isotretinoin—Pain—Epirubicin—ovarian cancer	0.00011	0.000194	CcSEcCtD
Isotretinoin—Constipation—Epirubicin—ovarian cancer	0.00011	0.000194	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—PGR—ovarian cancer	0.000109	0.00037	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000108	0.000191	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000108	0.000365	CbGpPWpGaD
Isotretinoin—Insomnia—Doxorubicin—ovarian cancer	0.000107	0.000189	CcSEcCtD
Isotretinoin—Paraesthesia—Doxorubicin—ovarian cancer	0.000106	0.000188	CcSEcCtD
Isotretinoin—Dyspnoea—Doxorubicin—ovarian cancer	0.000106	0.000187	CcSEcCtD
Isotretinoin—Feeling abnormal—Epirubicin—ovarian cancer	0.000106	0.000187	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000106	0.000358	CbGpPWpGaD
Isotretinoin—Somnolence—Doxorubicin—ovarian cancer	0.000105	0.000186	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000105	0.000185	CcSEcCtD
Isotretinoin—Dyspepsia—Doxorubicin—ovarian cancer	0.000104	0.000184	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000104	0.000353	CbGpPWpGaD
Isotretinoin—Decreased appetite—Doxorubicin—ovarian cancer	0.000103	0.000182	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000102	0.000181	CcSEcCtD
Isotretinoin—Fatigue—Doxorubicin—ovarian cancer	0.000102	0.000181	CcSEcCtD
Isotretinoin—Urticaria—Epirubicin—ovarian cancer	0.000102	0.00018	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—PARP1—ovarian cancer	0.000101	0.000344	CbGpPWpGaD
Isotretinoin—Pain—Doxorubicin—ovarian cancer	0.000101	0.000179	CcSEcCtD
Isotretinoin—Constipation—Doxorubicin—ovarian cancer	0.000101	0.000179	CcSEcCtD
Isotretinoin—Abdominal pain—Epirubicin—ovarian cancer	0.000101	0.000179	CcSEcCtD
Isotretinoin—Body temperature increased—Epirubicin—ovarian cancer	0.000101	0.000179	CcSEcCtD
Isotretinoin—Feeling abnormal—Doxorubicin—ovarian cancer	9.77e-05	0.000173	CcSEcCtD
Isotretinoin—RXRA—Metabolism—YAP1—ovarian cancer	9.72e-05	0.000329	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Doxorubicin—ovarian cancer	9.7e-05	0.000171	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.62e-05	0.000326	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP2—ovarian cancer	9.55e-05	0.000324	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Epirubicin—ovarian cancer	9.44e-05	0.000167	CcSEcCtD
Isotretinoin—Urticaria—Doxorubicin—ovarian cancer	9.42e-05	0.000166	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—ovarian cancer	9.38e-05	0.000166	CcSEcCtD
Isotretinoin—Abdominal pain—Doxorubicin—ovarian cancer	9.38e-05	0.000166	CcSEcCtD
Isotretinoin—Asthenia—Epirubicin—ovarian cancer	9.2e-05	0.000162	CcSEcCtD
Isotretinoin—Pruritus—Epirubicin—ovarian cancer	9.07e-05	0.00016	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.79e-05	0.000298	CbGpPWpGaD
Isotretinoin—Diarrhoea—Epirubicin—ovarian cancer	8.77e-05	0.000155	CcSEcCtD
Isotretinoin—Hypersensitivity—Doxorubicin—ovarian cancer	8.74e-05	0.000154	CcSEcCtD
Isotretinoin—Asthenia—Doxorubicin—ovarian cancer	8.51e-05	0.00015	CcSEcCtD
Isotretinoin—Dizziness—Epirubicin—ovarian cancer	8.48e-05	0.00015	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.46e-05	0.000287	CbGpPWpGaD
Isotretinoin—Pruritus—Doxorubicin—ovarian cancer	8.39e-05	0.000148	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—ERBB2—ovarian cancer	8.36e-05	0.000283	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PPP2R1A—ovarian cancer	8.23e-05	0.000279	CbGpPWpGaD
Isotretinoin—Vomiting—Epirubicin—ovarian cancer	8.15e-05	0.000144	CcSEcCtD
Isotretinoin—Diarrhoea—Doxorubicin—ovarian cancer	8.11e-05	0.000143	CcSEcCtD
Isotretinoin—Rash—Epirubicin—ovarian cancer	8.08e-05	0.000143	CcSEcCtD
Isotretinoin—Dermatitis—Epirubicin—ovarian cancer	8.07e-05	0.000143	CcSEcCtD
Isotretinoin—Headache—Epirubicin—ovarian cancer	8.03e-05	0.000142	CcSEcCtD
Isotretinoin—RXRA—Metabolism—FASN—ovarian cancer	7.92e-05	0.000269	CbGpPWpGaD
Isotretinoin—Dizziness—Doxorubicin—ovarian cancer	7.84e-05	0.000139	CcSEcCtD
Isotretinoin—RXRA—Metabolism—SLC5A5—ovarian cancer	7.79e-05	0.000264	CbGpPWpGaD
Isotretinoin—Nausea—Epirubicin—ovarian cancer	7.61e-05	0.000134	CcSEcCtD
Isotretinoin—Vomiting—Doxorubicin—ovarian cancer	7.54e-05	0.000133	CcSEcCtD
Isotretinoin—RXRA—Metabolism—SLC2A1—ovarian cancer	7.53e-05	0.000255	CbGpPWpGaD
Isotretinoin—Rash—Doxorubicin—ovarian cancer	7.48e-05	0.000132	CcSEcCtD
Isotretinoin—Dermatitis—Doxorubicin—ovarian cancer	7.47e-05	0.000132	CcSEcCtD
Isotretinoin—Headache—Doxorubicin—ovarian cancer	7.43e-05	0.000131	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.37e-05	0.00025	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CTNNB1—ovarian cancer	7.32e-05	0.000248	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1B1—ovarian cancer	7.22e-05	0.000245	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP9—ovarian cancer	7.17e-05	0.000243	CbGpPWpGaD
Isotretinoin—Nausea—Doxorubicin—ovarian cancer	7.04e-05	0.000124	CcSEcCtD
Isotretinoin—RARG—Gene Expression—MAPK3—ovarian cancer	6.96e-05	0.000236	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MYC—ovarian cancer	6.77e-05	0.000229	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—VEGFA—ovarian cancer	6.44e-05	0.000218	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PPP2R1A—ovarian cancer	6.4e-05	0.000217	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—STAT3—ovarian cancer	6.38e-05	0.000216	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.37e-05	0.000216	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NRAS—ovarian cancer	6.36e-05	0.000216	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MAPK3—ovarian cancer	6.36e-05	0.000216	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—ovarian cancer	6.3e-05	0.000213	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MAPK3—ovarian cancer	6.24e-05	0.000211	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MYC—ovarian cancer	6.19e-05	0.00021	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MAPK3—ovarian cancer	6.09e-05	0.000207	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MYC—ovarian cancer	6.07e-05	0.000206	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MAPK3—ovarian cancer	5.98e-05	0.000203	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MAPK3—ovarian cancer	5.98e-05	0.000203	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCB1—ovarian cancer	5.94e-05	0.000201	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TYMS—ovarian cancer	5.84e-05	0.000198	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ESR1—ovarian cancer	5.83e-05	0.000198	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MYC—ovarian cancer	5.82e-05	0.000197	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—ovarian cancer	5.82e-05	0.000197	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MAPK1—ovarian cancer	5.8e-05	0.000197	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EGFR—ovarian cancer	5.8e-05	0.000196	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KRAS—ovarian cancer	5.48e-05	0.000186	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CAV1—ovarian cancer	4.7e-05	0.000159	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—AKT1—ovarian cancer	4.69e-05	0.000159	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HRAS—ovarian cancer	4.66e-05	0.000158	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.49e-05	0.000152	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IL6—ovarian cancer	4.46e-05	0.000151	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—AKT1—ovarian cancer	4.29e-05	0.000145	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CG—ovarian cancer	4.28e-05	0.000145	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AKT1—ovarian cancer	4.21e-05	0.000143	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—AKT1—ovarian cancer	4.11e-05	0.000139	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AKT1—ovarian cancer	4.03e-05	0.000137	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AKT1—ovarian cancer	4.03e-05	0.000137	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CD—ovarian cancer	3.77e-05	0.000128	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CB—ovarian cancer	3.28e-05	0.000111	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MAPK3—ovarian cancer	3.12e-05	0.000106	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MYC—ovarian cancer	3.03e-05	0.000103	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTEN—ovarian cancer	2.84e-05	9.61e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AKT1—ovarian cancer	2.1e-05	7.13e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CA—ovarian cancer	2e-05	6.78e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKT1—ovarian cancer	1.63e-05	5.54e-05	CbGpPWpGaD
